Histamine Biosynthesis
The formation of this biogenic amine occurs in specialized structures of the body. The primary sites of synthesis are mast cells and basophils. In addition, production is active in gastric cells and neurons.
From a chemical standpoint, histamine formation is a classic decarboxylation reaction. The starting substrate is the amino acid histidine. Under the action of the specific enzyme histidine decarboxylase, carbon dioxide ($CO_2$) is cleaved from the amino acid molecule, yielding the target product—histamine. A critical prerequisite for this reaction to proceed is the presence of a cofactor, pyridoxal phosphate (PLP), which is the active form of vitamin $B_6$.
Inactivation Pathways: Oxidative Deamination
To prevent excessive histamine action, reliable degradation mechanisms exist in tissues. The first key pathway is oxidative deamination.
This process is catalyzed by the enzyme diamine oxidase (DAO), often referred to as histaminase. During this enzymatic conversion, the biogenic amine molecule is first transformed into an intermediate product—imidazole acetaldehyde. This aldehyde is then further oxidized, and the final metabolite of this pathway becomes imidazoleacetic acid.
In the context of biochemistry board examinations, it is important to clearly differentiate this product from other biogenic amine metabolites (such as homovanillic, 5-hydroxyindoleacetic, or vanillylmandelic acids)—imidazoleacetic acid is the specific marker of histamine deamination.
Inactivation Pathways: Methylation
The second, equally significant pathway for histamine clearance is based on a methylation reaction.
In this case, the enzyme histamine N-methyltransferase is engaged. To transfer the methyl group, this enzyme strictly requires a donor molecule: SAM (S-adenosylmethionine). As a result of attaching a methyl group to the histamine molecule, an inactive product termed N-methylhistamine is formed.